How many clinical trials are there for MTOR?

PlainTrial tracks 1 US clinical trials for MTOR, of which 0 are currently recruiting.

Which interventions appear most often on MTOR trial records?

Everolimus is the most-linked intervention name on MTOR records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for MTOR?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

MTOR: early-phase trial registry

Compiled by PlainTrial · August 8, 2026

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Browse conditions → How counts are built

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

MTOR: 1 US clinical trial tracked, none currently recruiting.

MTOR is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Dana-Farber Cancer Institute, running 1 of these trials.

Enrollment posture brief

Registry condition mtor

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Open-enrollment share among volume-matched conditions near MTOR

MTOR has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for MTOR on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

MTOR is recruiting below its size-band peers.

0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Indexed trials (enrollment closed)

1 total, page 1 of 1

COMPLETED Phase 2 30 participants

Everolimus for Cancer With TSC1 or TSC2 Mutation

Dana-Farber Cancer Institute

NCT02201212

Phase Distribution

Phase	Trial count
Phase 2	1

Top Sponsors

Dana-Farber Cancer Institute 1 trials

Named interventions

Most-linked intervention names on MTOR records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Everolimus Drug

1 trials

US sites by state

Facility locations filed on MTOR trials. A trial with sites in several states counts in each.

New York 1 trials

Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this MTOR page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

No MTOR trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
Dana-Farber Cancer Institute sponsors the most MTOR trials on record, review their full trial history before evaluating a specific study. See Dana-Farber Cancer Institute's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This MTOR condition card totals 1 registered trials; most-linked intervention Everolimus; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.